Value of Imaging in Diagnosis and Follow-up of Crohn's Disease Complicated with Intestinal Stricture
-
摘要: 肠腔狭窄是常见的克罗恩病(Crohn's disease,CD)并发症,15%的CD患者在首诊10年内可发展为肠腔狭窄。CD并发肠腔狭窄根据病理类型可分为炎症型、纤维型及混合型,炎症型为主的患者可通过药物治疗缓解症状,而纤维型为主的患者则只能通过介入或手术治疗,故采用影像学手段全面评估狭窄肠段的数目、部位、形态,并区分肠壁炎症和纤维化程度,对于临床决策十分重要。近年来,多项影像学新技术在鉴别狭窄肠壁炎症及纤维化方面取得了较大进展,有望在临床推广应用,进一步提高CD并发肠腔狭窄的诊疗。本文综述主要影像学手段包括内镜、CT、MRI、经腹超声等对肠腔狭窄的诊断价值,以期为临床提供参考。Abstract: Intestinal stricture is one of the most common complications of Crohn's disease(CD). About 15% of CD patients can develop intestinal stricture within the first 10 years after diagnosis. CD complicated with intestinal stricture can be divided into inflammatory, fibrous and mixed types according to pathological changes. Patients with the inflammatory type can alleviate symptoms by drug treatment. In patients with the fibrous type, the affected intestinal segments can only be treated by interventional or surgical treatment. Therefore, it is very important for clinical decision-making to comprehensively evaluate the number, location and shape of narrow intestinal segments, and to distinguish the degree of inflammation and fibrosis of the intestinal wall. This article reviews the sensitivity and specificity of the main imaging methods including endoscopy, CT, MRI, and trans-abdominal ultrasound in the diagnosis of intestinal stricture. In recent years, many new imaging techniques have made great progress in differentiating inflammation and fibrosis of the narrow intestinal wall, which is expected to be widely used in clinical practice and to further improve the diagnosis and treatment of CD complicated with intestinal stricture.
-
Key words:
- Crohn's disease /
- intestinal stricture /
- imaging
作者贡献:庄楠负责文献查询、整理及文章撰写;李文波、朱庆莉负责文章审阅和修改。利益冲突: 无 -
表 1 不同影像学方法诊断CD合并肠腔狭窄的优势和局限性
影像学方法 优势 局限性 内镜 直观,可取活检、镜下治疗 不适于肠梗阻患者,具有侵入性 CTE 非侵入性 需肠道准备,有辐射暴露 MRI 无辐射,准确度高 价格昂贵,检查时间长 经腹超声 准确度高,操作简便 易受肠腔内气体干扰 PET/CT 可准确识别严重病变 价格昂贵,对轻度病变不敏感 CD:克罗恩病;CTE:计算机断层扫描肠道成像;PET/CT:正电子发射断层显像/计算机体层成像 -
[1] Chan W, Mourad F, Leong RW. Crohn's disease associated strictures[J]. J Gastroenterol Hepatol, 2018, 33: 998-1008. doi: 10.1111/jgh.14119 [2] Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort[J]. Gastroenterology, 2010, 139: 1147-1155. doi: 10.1053/j.gastro.2010.06.070 [3] Shen B, Kochhar G, Navaneethan U, et al. Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group[J]. Lancet Gastroenterol Hepatol, 2020, 5: 393-405. doi: 10.1016/S2468-1253(19)30366-8 [4] Yaffe BH, Korelitz BI. Prognosis for nonoperative manage-ment of small-bowel obstruction in Crohn's disease[J]. J Clin Gastroenterol, 1983, 5: 211-215. doi: 10.1097/00004836-198306000-00003 [5] Rieder F, Zimmermann EM, Remzi FH, et al. Crohn's disease complicated by strictures: a systematic review[J]. Gut, 2013, 62: 1072-1084. doi: 10.1136/gutjnl-2012-304353 [6] Rieder F, Latella G, Magro F, et al. European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease[J]. J Crohns Colitis, 2016, 10: 873-885. doi: 10.1093/ecco-jcc/jjw055 [7] Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn's disease: a systematic review and meta-analysis[J]. Dis Colon Rectum, 2007, 50: 1968-1986. doi: 10.1007/s10350-007-0279-5 [8] Gomollon F, Dignass A, Annese V, et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management[J]. J Crohns Colitis, 2017, 11: 3-25. doi: 10.1093/ecco-jcc/jjw168 [9] Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)[J]. Gut, 1989, 30: 983-989. doi: 10.1136/gut.30.7.983 [10] Daperno M, D'Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD[J]. Gastrointest Endosc, 2004, 60: 505-512. doi: 10.1016/S0016-5107(04)01878-4 [11] 吴现瑞, 郑晓彬, 沈博. 炎症性肠病合并肠腔狭窄的内镜治疗[J]. 中华炎性肠病杂志, 2018, 2: 19-22. doi: 10.3760/cma.j.issn.2096-367X.2018.01.007 Wu XR, Zheng XB, Shen B. Endoscopic treatment of inflammatory bowel disease with intestinal stricture[J]. Zhonghua Yan Xing Chang Bing Za Zhi, 2018, 2: 19-22. doi: 10.3760/cma.j.issn.2096-367X.2018.01.007 [12] Navaneethan U, Lourdusamy V, Njei B, et al. Endoscopic balloon dilation in the management of strictures in Crohn's disease: a systematic review and meta-analysis of non-randomized trials[J]. Surg Endosc, 2016, 30: 5434-5443. doi: 10.1007/s00464-016-4902-1 [13] Hoffmann JC, Heller F, Faiss S, et al. Through the endoscope balloon dilation of ileocolonic strictures: prognostic factors, complications, and effectiveness[J]. Int J Colorectal Dis, 2008, 23: 689-696. doi: 10.1007/s00384-008-0461-9 [14] Kanamori A, Sugaya T, Tominaga K, et al. Endoscopic balloon dilation for stenotic lesions in Crohn's disease[J]. Turk J Gastroenterol, 2017, 28: 117-124. doi: 10.5152/tjg.2017.16598 [15] Hesham W, Kann BR. Strictureplasty[J]. Clin Colon Rectal Surg, 2013, 26: 80-83. doi: 10.1055/s-0033-1348045 [16] Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn's disease: a systematic review and meta-analysis[J]. Dis Colon Rectum, 2007, 50: 1968-1986. doi: 10.1007/s10350-007-0279-5 [17] Sinh P, Shen B. Endoscopic evaluation of surgically altered bowel in patients with inflammatory bowel diseases[J]. Inflamm Bowel Dis, 2015, 21: 1459-1471. [18] Spiceland CM, Lodhia N. Endoscopy in inflammatory bowel disease: Role in diagnosis, management, and treatment[J]. World J Gastroenterol, 2018, 24: 4014-4020. doi: 10.3748/wjg.v24.i35.4014 [19] Adler J, Punglia DR, Dillman JR, et al. Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn's disease[J]. Inflamm Bowel Dis, 2012, 18: 849-856. doi: 10.1002/ibd.21801 [20] Chiorean MV, Sandrasegaran K, Saxena R, et al. Correla-tion of CT enteroclysis with surgical pathology in Crohn's disease[J]. Am J Gastroenterol, 2007, 102: 2541-2550. doi: 10.1111/j.1572-0241.2007.01537.x [21] Pous-Serrano S, Frasson M, Palasi GR, et al. Accuracy of magnetic resonance enterography in the preoperative assessment of patients with Crohn's disease of the small bowel[J]. Colorectal Dis, 2017, 19: O126-O133. doi: 10.1111/codi.13613 [22] Kumar S, Hakim A, Alexakis C, et al. Small intestinal contrast ultrasonography for the detection of small bowel complications in Crohn's disease: correlation with intraoperative findings and magnetic resonance enterography[J]. J Gastroenterol Hepatol, 2015, 30: 86-91. doi: 10.1111/jgh.12724 [23] Bouhnik Y, Carbonnel F, Laharie D, et al. Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study[J]. Gut, 2018, 67: 53-60. doi: 10.1136/gutjnl-2016-312581 [24] Choi SH, Kim KW, Lee JY, et al. Diffusion-weighted Magnetic Resonance Enterography for Evaluating Bowel Inflammation in Crohn's Disease: A Systematic Review and Meta-analysis[J]. Inflamm Bowel Dis, 2016, 22: 669-679. doi: 10.1097/MIB.0000000000000607 [25] Del VR, Sansoni I, Caviglia R, et al. Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease[J]. Abdom Imaging, 2008, 33: 417-424. doi: 10.1007/s00261-007-9267-4 [26] Adler J, Swanson SD, Schmiedlin-Ren P, et al. Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease[J]. Radiology, 2011, 259: 127-135. doi: 10.1148/radiol.10091648 [27] Li XH, Mao R, Huang SY, et al. Characterization of Degree of Intestinal Fibrosis in Patients with Crohn Disease by Using Magnetization Transfer MR Imaging[J]. Radiology, 2018, 287: 494-503. doi: 10.1148/radiol.2017171221 [28] Maconi G, Carsana L, Fociani P, et al. Small bowel stenosis in Crohn's disease: clinical, biochemical and ultrasonographic evaluation of histological features[J]. Aliment Pharmacol Ther, 2003, 18: 749-756. doi: 10.1046/j.1365-2036.2003.01673.x [29] 王妙倩, 李文波, 朱庆莉, 等. 超声检查与计算机断层扫描肠道成像对克罗恩病诊断价值的对比[J]. 中华消化杂志, 2018, 38: 121-125. doi: 10.3760/cma.j.issn.0254-1432.2018.02.012 Wang MQ, Li WB, Zhu QL, et al. Comparison of the value of abdominal ultrasonography and computed tomography enterography in the diagnosis of Crohn's disease[J]. Zhonghua Xiao Hua Za Zhi, 2018, 38: 121-125. doi: 10.3760/cma.j.issn.0254-1432.2018.02.012 [30] Pallotta N, Vincoli G, Montesani C, et al. Small intestine contrast ultrasonography (SICUS) for the detection of small bowel complications in crohn's disease: a prospective comparative study versus intraoperative findings[J]. Inflamm Bowel Dis, 2012, 18: 74-84. doi: 10.1002/ibd.21678 [31] Kratzer W, von Tirpitz C, Mason R, et al. Contrast-enhanced power Doppler sonography of the intestinal wall in the differentiation of hypervascularized and hypovascularized intestinal obstructions in patients with Crohn's disease[J]. J Ultrasound Med, 2002, 21: 149-157, 158-159. doi: 10.7863/jum.2002.21.2.149 [32] Ripolles T, Rausell N, Paredes JM, et al. Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn's disease: a comparison with surgical histopathology analysis[J]. J Crohns Colitis, 2013, 7: 120-128. doi: 10.1016/j.crohns.2012.03.002 [33] Chen YJ, Mao R, Md XL, et al. Real-Time Shear Wave Ultrasound Elastography Differentiates Fibrotic from Inflamma-tory Strictures in Patients with Crohn's Disease[J]. Inflamm Bowel Dis, 2018, 24: 2183-2190. doi: 10.1093/ibd/izy115 [34] Dillman JR, Stidham RW, Higgins PD, et al. US elastography-derived shear wave velocity helps distinguish acutely inflamed from fibrotic bowel in a Crohn disease animal model[J]. Radiology, 2013, 267: 757-766. doi: 10.1148/radiol.13121775 [35] Louis E, Ancion G, Colard A, et al. Noninvasive assess-ment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT[J]. J Nucl Med, 2007, 48: 1053-1059. doi: 10.2967/jnumed.107.040436 [36] Bettenworth D, Reuter S, Hermann S, et al. Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammation[J]. J Nucl Med, 2013, 54: 748-755. doi: 10.2967/jnumed.112.112623 [37] Bettenworth D, Nowacki TM, Cordes F, et al. Assessment of stricturing Crohn's disease: Current clinical practice and future avenues[J]. World J Gastroenterol, 2016, 22: 1008-1016. doi: 10.3748/wjg.v22.i3.1008 [38] Jacene HA, Ginsburg P, Kwon J, et al. Prediction of the need for surgical intervention in obstructive Crohn's disease by 18 F-FDG PET/CT[J]. J Nucl Med, 2009, 50: 1751-1759. doi: 10.2967/jnumed.109.065466 [39] Lenze F, Wessling J, Bremer J, et al. Detection and differentiation of inflammatory versus fibromatous Crohn's disease strictures: prospective comparison of 18 F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluation[J]. Inflamm Bowel Dis, 2012, 18: 2252-2260. doi: 10.1002/ibd.22930 [40] Bettenworth D, Bokemeyer A, Baker M, et al. Assessment of Crohn's disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review[J]. Gut, 2019, 68: 1115-1126. doi: 10.1136/gutjnl-2018-318081